Market Currents
The FDA has delayed by three months a decision on whether Gilead (GILD) can expand the use of...
-
Friday, June 8, 2012, 4:49 PM ETThe FDA has delayed by three months a decision on whether Gilead (GILD) can expand the use of its HIV treatment Truvada as a therapy to prevent the disease. The date was moved tentatively to September 14 in order for the agency to review GILD's plan to ensure people won’t misuse the drug.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: